State‐of‐art of cellular therapy for acute leukemia

15Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

With recent clinical breakthroughs, immunotherapy has become the fourth pillar of cancer treatment. Particularly, immune cell‐based therapies have been envisioned as a promising treatment option with curative potential for leukemia patients. Hence, an increasing number of preclinical and clinical studies focus on various approaches of immune cell‐based therapy for treatment of acute leukemia (AL). However, the use of different immune cell lineages and subsets against different types of leukemia and patient disease statuses challenge the interpretation of the clinical applicability and outcome of immune cell‐based therapies. This review aims to provide an overview on recent approaches using various immune cell‐based therapies against acute B‐, T‐, and myeloid leukemias. Further, the apparent limitations observed and potential approaches to overcome these limitations are discussed.

Cite

CITATION STYLE

APA

Lee, J. B., Vasic, D., Kang, H., Fang, K. K. L., & Zhang, L. (2021, May 1). State‐of‐art of cellular therapy for acute leukemia. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms22094590

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free